Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on August 17, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Health and Human Services (HHS) - Wide Procurement of Biosafety Level 4 (BSL-4) Suits- Personal Protective Equipment

Closed
R75N98026Q00738Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are conducting a sole-source, firm-fixed-price acquisition to procure Honeywell-brand Biosafety Level 4 (BSL-4) positive pressure suits. This mission-critical procurement is intended to support researchers and personnel working in high-containment laboratory environments with high-risk pathogens. The acquisition is being awarded to Protective Industrial Products, Inc. because Honeywell is the only manufacturer providing suits that integrate seamlessly with established NIH and CDC laboratory infrastructure. The total estimated contract value, including all options, is $3,075,975. The period of performance is scheduled to begin on August 17, 2026, and includes a base year followed by two option years, potentially extending through August 16, 2029. The required protective equipment must meet rigorous safety and technical specifications to ensure researcher safety and facility compatibility. Key requirements include a suit weight of 10 lbs or less, a 300-degree visor for visibility, and a light color to ensure contamination is easily detectable. The suits must maintain an internal temperature below 26C during five hours of continuous use and provide a breathing air flow rate of 16-34 CFM with internal HEPA filtration. Additionally, the suits must be chemically compatible with BSL-4 disinfectants, feature smooth seams for decontamination, and be available in at least five sizes. The contract anticipates a demand of approximately 200 suits per year and requires products to have a minimum shelf life of five years and the ability to pass quantitative pressure decay testing.

General Info

NIH sole-source contract for Honeywell BSL-4 suits valued at 3,075,975 dollars through 2029.

NAICS

339999 - All Other Miscellaneous Manufacturing

Place of Performance

Latham, NY, 12110, USA

Set-Aside

NONE

Documents

2

75N98026Q00738 - BSL-4 Positive Pressure Suits

PDF, High priority: read this first4 pages · rfq
High

R75N98026Q00738 Non-Competitive Combined Synopsis/Solicitation for BSL-4 Protective Suits

PDF, High priority: read this first4 pages · combined-synopsis-solicitation
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Combined Synopsis

Notice updated

Notice details unchanged. Attachments may have changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA

Full Description

Show more

The purpose of this acquisition is to obtain multiple models of BSL-4 Positive Pressure Suits for use


at the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention


(CDC). The NIH Division of Logistics Services (DLS), through the Office of Logistics and


Acquisition Operations (OLAO), OALM, NIH, intends to award a sole-source firm-fixedprice


purchase order to Protective Industrial Products, Inc. (WX8TVG6ZFT64). The total estimated


value of the purchase order, inclusive of all options, is $3,075,975 (see breakdown in the table


below). The Government projects award no later than August 17, 2026. The planned period of


performance is a base and two option years, commencing on August 17, 2026, through


August 16, 2029, (if all option periods are exercised).


The Office of Logistics and Acquisition Operations (OLAO) within OALM, NIH,


anticipates awarding one purchase order for Biosafety Level 4 (BSL-4) positive pressure suits to support


NIH and CDC personnel and researchers.




The required procurement is for Honeywell brand protective suits designed specifically for life science


personnel working within high-containment BSL-4 laboratory environments dealing with high-risk


pathogens and deadly biological agents. Multiple models of BSL-4 positive pressure suits within the


Honeywell product line will be procured under acquisition for mission critical functions.



The requirement to procure the Honeywell brand is specific to this manufacturer, as no other vendor


produces a functional equivalent that integrates seamlessly into the established laboratory


infrastructure. The Honeywell suit is the only option among the marketplace that meets the salient


characteristics (see table below) required for the specific research environments in NIH’s National


Institute of National Institute of Allergy and Infectious Diseases (NIAID) and CDC. The following table


lists the required safety criteria for BSL-4 positive pressure suits:



Required Safety Criteria for BSL-4 Positive Pressure Suits



Manufacturer must be able to meet demands of NIH facilities with need of ~200 per year


Must be durable to withstand repeated use without defects


Must demonstrate chemical compatibility with disinfectants used in the BSL-4 without degradation


Suit ensemble must be offered in at least 5 unique and different sizes (S, M, L, XL, 2XL)


Breathing airlines must be placed to accommodate human physiology


Suit must not have noise levels that require hearing protection


Breathing air flow rate must be 16-34 cubic feet per minute (CFM)


Airline specifications must work with NIH BSL-4 facilities design (e.g., 80-100 psi maximum with 60 psi operational set point)


Exhaust valves must be protected from direct chemical or other hazardous liquid splashes, must automatically seal upon disconnection from breathing air, and must have internal screens to protect from interference


Suit gloves must attach to the suit using interface components to secure them to the suit and allow use of gloves currently in use at NIH BSL-4 facilities


Suit must include internal HEPA filter on the breathing air line


The color must be light so that splashes or contamination is easily visible on the surface


Seams must be smooth to ensure effective decontamination with no excess fabric


Temperature in the suit must not exceed 26C during continuous use for up to 5 hours


Suit must have two different options for footwear, either with an attached outer boot or stocking feet that can be slipped into external shoes


Must have shelf life of at least 5 years


Suit must be designed in such a way that it can be tested by quantitative pressure decay test to ensure proper function and seal


Visor or headpiece must have 300 degrees of transparency to ensure proper visibility of surroundings


Suit must weigh less than or equal to10 lbs. to minimize stress to the user.



Please see attached CSS document for full details.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 541614
New
Federal
R--RADx Coordination Center Notice of Intent
Solicitation # 75N98026R00176
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has issued a Notice of Intent under solicitation 75N98026R00176 to award a non-competitive modification to IDIQ Contract No. 75N92022D00014. This modification intends to increase the contract ceiling for the Massachusetts General Hospital Consortia for Improving Medicine with Innovation and Technology (CIMIT) to support the Rapid Acceleration of Diagnostics (RADx-Tech) initiative. The initiative operates as an innovation funnel to accelerate the development, commercialization, and implementation of health technologies through a collaborative network consisting of a Coordination Center for operational oversight and workflows, a Commercialization Center for subject matter expert selection, and a Validation Center for technical and clinical verification. The government anticipates issuing the modification around December 2026. While this is a non-competitive intent, interested parties may submit capability statements via email to the contracting officer, Melanie Suarez, or contract specialist, Noelle Decenzo, by November 2, 2026. Submissions must reference the notice number and include details regarding employee count, professional qualifications of technical personnel, available facilities and equipment, and an outline of similar previous research projects. All responding parties must maintain an active registration in the System for Award Management (SAM).
Process, Physical Distribution, and Logistics Consulting Services

POSTED

5 days ago

DEADLINE

in 12 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS